To include your compound in the COVID-19 Resource Center, submit it here.

No rejected requests under GSK transparency initiative

As of Sept. 20, five research proposals requesting patient-level data from GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) under the pharma's January open access initiative

Read the full 220 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE